作者：
Caitlin A,Creasy [1]
;
Yuzhong Jeff,Meng [2]
;
Marie-Andrée,Forget [3]
;
Tatiana,Karpinets [4]
;
Katarzyna,Tomczak [1]
;
Chip,Stewart [5]
;
Carlos A,Torres-Cabala [6]
;
Shari,Pilon-Thomas [2]
;
Amod A,Sarnaik [7]
;
James J,Mulé [8]
;
Levi,Garraway [9]
;
Matias,Bustos [9]
;
Jianhua,Zhang [8]
;
Sapna P,Patel [2]
;
Adi,Diab [3]
;
Isabella C,Glitza [4]
;
Cassian,Yee [10]
;
Hussein,Tawbi [5]
;
Michael K,Wong [1]
;
Jennifer,McQuade [1]
;
Dave S B,Hoon [1]
;
Michael A,Davies [1]
;
Patrick,Hwu [1]
;
Rodabe N,Amaria [1]
;
Cara,Haymaker [1]
;
Rameen,Beroukhim [10]
;
Chantale,Bernatchez [1]
作者单位：
Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
[1]
Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[2]
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[3]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[4]
Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.
[5]
Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas.
[6]
Department of Pathology, The University of Texas MDACC, Houston, Texas.
[7]
Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
[8]
Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
[9]
Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California.
[10]
DOI
10.1158/1078-0432.CCR-21-1060
PMID
35190823
发布时间
2022-11-04
换一批
换一批
